Performance for the quarter ended September 2016

The top-line grew 11% at Rs 600.42 crore. Both feminine care and health care business continued to deliver strong double digit sales growth in a competitive market environment behind superior value propositions, strength of product portfolio and improved in store execution.

OPM has inclined by 720 bps to 25.2% due to decrease in other expenses and raw & packaging material. The operating profit increased by 56% to Rs 151.16 crore.

Other income increased by 6% to Rs 22.51 crore. Interest cost decreased by 74% to Rs 0.43 crore. Depreciation was flat at Rs 12.71 crore. PBT has increased by 55% to Rs 160.53 crore.

The tax outgo inclined by 64% to Rs 56.09 crore. The effective tax rate inclined from 33% to 34.9%. The net profit has increased by 50% to Rs 104.44 crore. The company continues to focus on productivity and cost efficiency.

Performance for fiscal year ended June 2016

The top-line inclined by 6% to Rs 2484.33 crore. The Feminine care business continued to deliver strong double digit sales growth in a competitive market environment behind superior value propositions and strength of product portfolio. Due to category slowdown, sales in the Health Care Business remained flat.

OPM has inclined by 360 bps to 24.3% due to fall in raw material cost, purchase of stock in trade and ASP. The operating profit increased by 25% to Rs 604.64 crore.

Other income increased by 17% to Rs 87.61 crore. Interest cost decreased by 30% to Rs 4.02 crore. Depreciation declined by 2% to Rs 51.69 crore. PBT has increased by 27% to Rs 636.54 crore.

The tax outgo inclined by 38% to Rs 213.36 crore. The effective tax rate increased from 30.9% to 33.5%. The net profit has increased by 22% to Rs 423.18 crore due to increase in margin.

The promoters hold 70.64% stake in the company

The shares of the company are trading around Rs 6693 at BSE.